MedPath

Brief Interventions on Smoking for Hormonal Contraceptive Users

Not Applicable
Completed
Conditions
Smoking
Registration Number
NCT00726141
Lead Sponsor
University of Luebeck
Brief Summary

Despite rising smoker rates, particularly in girls and young women, only few studies have focused on smoking cessation in young smokers. Gynaecologist practices may be an ideal setting to proactively intervene with young female smokers. Elevated health risks of smoking while using hormonal contraceptives could be a successful approach to gain young women's attention on smoking cessation. The purpose of this study is to evaluate the effectiveness of a smoking cessation intervention for girls and young women visiting gynaecologist practices and using hormonal contraceptives.

Detailed Description

In the randomized controlled trial, female smokers aged 14-25 will be recruited in practices of gynaecologists. Intervention within the practice consists of a 30 minutes counseling session based on Motivational Interviewing, a standardised physician letter focusing on the elevated health risks of smoking while using hormonal contraceptives and a stage-matched self-help manual. After four weeks, an expert system feedback letter will be sent. In the intervention group, no smoking intervention will be given. Follow-up assessments will be conducted after 12 months, including saliva cotinine measures.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
699
Inclusion Criteria

Not provided

Exclusion Criteria
  • Pregnancy
  • Emergency treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Smoking cessation12 months
Secondary Outcome Measures
NameTimeMethod
Readiness to change variables12 months
Reduction of smoking12 months
Level of nicotine dependence12 months
Quit attempts12 months

Trial Locations

Locations (1)

University of Lübeck

🇩🇪

Lübeck, Germany

© Copyright 2025. All Rights Reserved by MedPath